Doripenem

CAS No. 148016-81-3

Doripenem( —— )

Catalog No. M22509 CAS No. 148016-81-3

Doripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
5MG 29 In Stock
10MG 42 In Stock
25MG 69 In Stock
50MG 114 In Stock
100MG 166 In Stock
200MG Get Quote In Stock
500MG 414 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Doripenem
  • Note
    Research use only, not for human use.
  • Brief Description
    Doripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.
  • Description
    Doripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    antibiotic
  • Research Area
    infection;Urinary system;Respiratory system
  • Indication
    Infection|Cross Infection|Bacterial Infections|Pneumonia, Ventilator-Associated|Intra-abdominal Infections|Urinary Tract Infections

Chemical Information

  • CAS Number
    148016-81-3
  • Formula Weight
    420.5
  • Molecular Formula
    C15H24N4O6S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wagenlehner, Florian, M, et al. Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program[J]. Clinical Infectious Diseases, 2016.
molnova catalog
related products
  • DS-2969b

    DS-2969b (DS 11960558) is a novel orally active GyrB inhibitor, inhibits the supercoiling activity of C. difficile DNA gyrase with IC50 of 20 ng/mL.

  • Cefoperazone sodium

    Cefoperazone sodium salt is a cephalosporin antibiotic for inhibition of rMrp2-mediated [3H]E217βG uptake with IC50 of 199 μM.

  • G907

    G907 is a potent, selective small-molecule antagonist of ATP-binding cassette (ABC) transporter MsbA with IC50 of 18 nM.